Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts.
Mendicino M, Liu M, Ghanekar A, He W, Koscik C, Shalev I, Javadi M, Turnbull J, Chen W, Fung L, Sakamoto S, Marsden P, Waddell TK, Phillips MJ, Gorczynski R, Levy GA, Grant D.
Mendicino M, et al.
Circulation. 2005 Jul 12;112(2):248-56. doi: 10.1161/CIRCULATIONAHA.105.534271. Epub 2005 Jul 5.
Circulation. 2005.
PMID: 15998670